DeepMed Research

BAXTER HEALTHCARE CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

Completed

Conditions: Acute Renal Failure
AKI - Acute Kidney Injury
CKD
ESRD

Interventions: Device: Vascular access catheter to support dialysis or CRRT

First Posted Date: 2023-06-05

Last Posted Date: 2025-03-13

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 76

Registration Number: NCT05888376

Locations: 🇵🇱
Independent Public Hospital No. 4, Lublin, Lublin, Poland
🇵🇱
Independent Public Health Care Unit, Łęczna, Łęczna, Poland

PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery

Completed

Conditions: Adhesion

Interventions: Device: ADEPT

First Posted Date: 2023-04-13

Last Posted Date: 2025-03-21

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 153

Registration Number: NCT05811585

Locations: 🇩🇪
Pius Hospital Oldenburg, Oldenburg, Germany
🇺🇸
Texas Fertility Center, Austin, Texas, United States

Starling/CRRT Observational Study

Withdrawn

Conditions: Hemodynamic Monitoring

Interventions: Device: Starling

First Posted Date: 2023-02-15

Last Posted Date: 2023-07-14

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT05729048

Locations: 🇺🇸
Baxter Investigational Site, Lexington, Kentucky, United States

BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)

Not Applicable

Active, not recruiting

Conditions: Congenital Heart Disease in Children

Interventions: Device: No Intervention
Device: BAX602

First Posted Date: 2022-12-12

Last Posted Date: 2024-07-22

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 34

Registration Number: NCT05647161

Locations: 🇯🇵
Aichi Children's Hospital and Medical Center, Obu City, Aichi Prefecture, Japan
🇯🇵
Hyogo Prefectural Kobe Children's Hospital, Kobe city, Hyogo, Japan
🇯🇵
Shizuoka Children's Hospital, Shizuoka City, Shizuoka Prefecture, Japan

and more 3 locations

Doxil/Caelyx BE Study

Phase 1

Completed

Conditions: Ovarian Cancer
AIDS-related Kaposi Sarcoma
Multiple Myeloma
Metastatic Breast Cancer

Interventions: Drug: DOXIL/CAELYX

First Posted Date: 2022-10-05

Last Posted Date: 2024-07-25

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 36

Registration Number: NCT05567601

Locations: 🇮🇳
Erode Cancer Centre, Erode, Tamil Nadu, India
🇮🇳
Indrayani Hospital, Pune, Maharashtra, India
🇮🇳
Medstar Speciality, Bangalore, Karnataka, India

and more 11 locations

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Phase 3

Recruiting

Conditions: Regional Citrate Anticoagulation (RCA)
Acute Kidney Injury (AKI)
Continuous Renal Replacement Therapy (CRRT)

Interventions: Drug: Prismocitrate 18
Device: PrisMax System Version 3.x with calcium line accessory

First Posted Date: 2022-06-01

Last Posted Date: 2025-04-27

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 40

Registration Number: NCT05399537

Locations: 🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States
🇺🇸
Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
🇺🇸
University of Southern California (USC) / Keck Hospital, Los Angeles, California, United States

and more 7 locations

Oscillation and Lung Expansion (OLE) for Treatment of Neuromuscular Disease Patients

Not Applicable

Terminated

Conditions: Neuromuscular Diseases

Interventions: Device: Oscillation and Lung Expansion (OLE) therapy

First Posted Date: 2022-05-09

Last Posted Date: 2024-12-12

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 41

Registration Number: NCT05366010

Locations: 🇺🇸
Science 37, Durham, North Carolina, United States

DermaClose DUKE Fasciotomy and Wound Study

Terminated

Conditions: Wound of Skin

Interventions: Device: Conventional wound dressings
Device: DermaClose Continuous External Tissue Expander Device
Device: DermaClose XL Continuous External Tissue Expander Device

First Posted Date: 2022-04-15

Last Posted Date: 2025-03-21

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 7

Registration Number: NCT05330767

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Theranova Randomized, Controlled, Trial (RCT) in China

Not Applicable

Completed

Conditions: Acute Kidney Failure
Chronic Kidney Failure

Interventions: Device: Theranova 400 Dialyzer
Device: FX 800 Dialyzer

First Posted Date: 2022-04-04

Last Posted Date: 2025-03-20

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 323

Registration Number: NCT05309291

Locations: 🇨🇳
Investigational Site, Suzhou, China

Cefazolin PK Study 3g vs 2g

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefazolin

First Posted Date: 2022-04-04

Last Posted Date: 2022-10-12

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 24

Registration Number: NCT05309304

Locations: 🇺🇸
Baxter Investigational Site, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy